Document Detail

Role of C-Reactive Protein in Acute Myocardial Infarction and Stroke: Possible Therapeutic Approaches.
MedLine Citation:
PMID:  21470166     Owner:  NLM     Status:  Publisher    
Myocardial infarction (MI) and stroke are relevant clinical issues in Western Countries for morbidity and mortality. In the last decades, great interest has been paid to the identification of non-traditional risk factors for a better stratification of patients and to recognize those at higher risk, who might particularly benefit from a more aggressive approach. In this field, C-reactive protein (CRP) is the most extensively studied novel marker, since it seems related to several stages of atherogenesis, from its beginning to clinical events (i.e. acute coronary syndromes - ACS). Among its possible pathogenetic role both in coronary artery disease (CAD) and ischemic stroke, several studies have shown that CRP could be used to predict first ever MI and stroke in healthy subjects, as well as outcome in acute settings. Moreover, a decrease of CRP levels can be achieved by several therapies, first of all statins, and this seems to be associated with a better outcome. Then a possible role for CRP to guide treatment of patient with ACS and stroke has been claimed and need to be specifically addressed by large randomized controlled trials.
Paolo Calabrò; Enrica Golia; Edward T H Yeh
Related Documents :
2400256 - Artificial mitral valve chordae: experimental and clinical experience.
7790336 - Ischemic papillary muscle dysfunction in an adult with a parachute mitral valve.
12000156 - Qualitative and quantitative evaluation of mitral valve morphology by intraoperative vo...
19997546 - Isolated left ventricular noncompaction cardiomyopathy accompanied by severe mitral reg...
11374756 - Recovery of cardiac function after standard hypothermic storage versus preservation wit...
25299966 - The 2013 acc/aha cardiovascular prevention guidelines improve alignment of statin thera...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-4-6
Journal Detail:
Title:  Current pharmaceutical biotechnology     Volume:  -     ISSN:  1873-4316     ISO Abbreviation:  -     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-4-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960530     Medline TA:  Curr Pharm Biotechnol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Division of Cardiology, Department of Cardiothoracic Sciences, Second University of Naples, Monaldi Hospital, Via L. Bianchi 80131 - Naples, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Roles of Connexins in Atherosclerosis and Ischemia-Reperfusion Injury.
Next Document:  Chemogenomic Approaches for the Exploration of GPCR Space.